Skip to content

The Bliss Study: Effect of deep BLock on Intraoperative Surgical conditions, perioperative hemodynamic status and respiratory parameters following reversal with Sugammadex in patients undergoing laparoscopic renal and prostate surgery.

The Bliss Study: Effect of deep BLock on Intraoperative Surgical conditions, perioperative hemodynamic status and respiratory parameters following reversal with Sugammadex in patients undergoing laparoscopic renal and prostate surgery. - BLISS study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37038
Enrollment
24
Registered
2012-06-25
Start date
2012-09-11
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopische renale en prostaatchirurgie anesthesia depth of anesthesia

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients that will undergo elective laparoscopoc renal or prostate surgery

Exclusion criteria

Exclusion criteria: (i) Known or suspected neuromuscular disorders impairing neuromuscular function; (ii) Allergies to muscle relaxants, anesthetics or narcotics; (iii) A (family) history of malignant hyperthermia; (iv) Patients who have a contraindication for neostigmine administration; (v) Women who are or may be pregnant or are currently breast feeding; (vi) Renal insufficiency, as defined by serum creatinine x 2 of normal, or urine output 35 kg/m2

Design outcomes

Primary

MeasureTime frame
To study the surgical conditions in patients undergoing laparoscopic renal or prostate surgery during deep versus less deep neuromuscular block as assessed by the surgical rating score.

Secondary

MeasureTime frame
Postoperative sedation, pain and respiration

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)